Bromfenac Ophthalmic Solution
Loading...Bromfenac Ophthalmic Solution Recall
Get an alert when a recall is issued.
Questions & Answers
Side Effects & Adverse Reactions
There is currently no warning information available for this product. We apologize for any inconvenience.
Legal Issues
There is currently no legal information available for this drug.
FDA Safety Alerts
There are currently no FDA safety alerts available for this drug.
Manufacturer Warnings
There is currently no manufacturer warning information available for this drug.
FDA Labeling Changes
There are currently no FDA labeling changes available for this drug.
Uses
Bromfenac Ophthalmic Solution, 0.09% is indicated for the treatment of postoperative inflammation and reduction of ocular pain in patients who have undergone cataract surgery.
History
There is currently no drug history available for this drug.
Other Information
Bromfenac Ophthalmic Solution, 0.09% is a sterile, topical, nonsteroidal anti-inflammatory drug (NSAID) for ophthalmic use. Each mL of Bromfenac Ophthalmic Solution, 0.09% contains 1.035 mg bromfenac sodium sesquihydrate (equivalent to 0.9 mg bromfenac free acid). Bromfenac sodium sesquihydrate is designated chemically as sodium 2-amino-3-(4-bromobenzoyl) phenyl acetate sesquihydrate, with an empirical formula of C15H11BrNNaO3• 3/2 H2O. The structural structure for bromfenac sodium sesquihydrate is:
Bromfenac sodium sesquihydrate is a yellow or orange yellow crystalline powder. The molecular weight of bromfenac sodium sesquihydrate is 383.17. Bromfenac Ophthalmic Solution is supplied as a sterile aqueous 0.09% solution, with a pH of 8.3. The osmolality of Bromfenac Ophthalmic Solution is approximately 300 mOsmol/kg.
Each mL of Bromfenac Ophthalmic Solution contains:
Active: bromfenac sodium sesquihydrate 0.1035%
Preservative: benzalkonium chloride (0.05 mg/mL)
Inactives: boric acid, edetate disodium dihydrate, polysorbate 80, povidone, sodium borate, sodium sulfite anhydrous, sodium hydroxide to adjust pH and water for injection.
Sources
Bromfenac Ophthalmic Solution Manufacturers
-
Apotex Corp.
![Bromfenac Ophthalmic Solution, 0.09% Solution/ Drops [Apotex Corp.]](/wp-content/themes/bootstrap/assets/img/loading2.gif)
Bromfenac Ophthalmic Solution | Apotex Corp.
2.1 Recommended DosingFor the treatment of postoperative inflammation in patients who have undergone cataract extraction, one drop of bromfenac ophthalmic solution should be applied to the affected eye once daily beginning 1 day prior to cataract surgery, continued on the day of surgery, and through the first 14 days of the postoperative period.
2.2 Use with Other Topical Ophthalmic MedicationsBromfenac ophthalmic solution may be administered in conjunction with other topical ophthalmic medications such as alpha-agonists, beta-blockers, carbonic anhydrase inhibitors, cycloplegics, and mydriatics. Drops should be administered at least 5 minutes apart.
Login To Your Free Account